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We describe an interesting clinical course of a patient who developed severe ischemic liver injury due 
to acute embolism of the superior mesenteric artery (SMA) and celiac artery.  A 70-year-old man was 
hospitalized for abdominal pain and diarrhea.  Abdominal computed tomography demonstrated a vari-
ant common hepatic artery arising from the SMA and multiple thromboembolic occlusions of visceral 
arteries,  including the SMA and celiac artery.  Laboratory data showed markedly elevated hepatic 
enzymes,  which increased after admission despite the initiation of systemic anticoagulant and throm-
bolytic therapy.  The patient was successfully treated by endovascular recanalization of the SMA 
occlusion via transcatheter embolus aspiration,  thrombolysis,  balloon angioplasty,  and stent place-
ment.  Severe ischemic liver injury may occur in the setting of synchronous embolism of the SMA and 
celiac artery,  and these phenomena may have a critical impact on the choice of treatment strategies 
and prognosis.  Endovascular treatment appears to an eﬀective treatment option.
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cute superior mesenteric artery (SMA) occlu-
sion is a life-threatening condition,  with bowel 
ischemia being the most critical complication.  Usually,  
liver ischemia is not a crucial problem in this condi-
tion.  Although ischemic liver injury can occur when 
acute SMA occlusion is accompanied by celiac artery 
occlusion,  this condition is rare with a limited number 
of published case reports [1-5].  Furthermore,  there 
is only 1 case report that describes endovascular 
treatment performed for such a condition [5].
　 The present report describes a unique case of 
acute thromboembolic occlusions of multiple visceral 
arteries,  including the SMA,  celiac artery,  and 
splenic artery,  that developed in a patient who had a 
variant common hepatic artery arising from the SMA.  
Ischemic liver injury,  rather than bowel ischemia,  was 
the most critical problem that dictated the course of 
treatment.  He was successfully treated by endovascu-
lar recanalization of the SMA occlusion.
Case Report
　 A 70-year-old man was admitted to our hospital 
because of abdominal pain and diarrhea lasting for 4 
days.  On physical examination,  the abdomen was soft,  
and there was slight upper abdominal tenderness.  
Laboratory examination on admission showed an ele-
vated white blood cell count (11,410/μL) and elevated 
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hepatic enzyme levels: aspartate aminotransaminase 
(AST),  alanine aminotransaminase (ALT),  and lactate 
dehydrogenase (LDH) of 832IU/L,  843IU/L,  and 
1,212IU/L,  respectively.  Creatine kinase (CK) was 
within the normal range.  Abdominal dynamic computed 
tomography (CT) demonstrated a variant common 
hepatic artery arising from the SMA.  The splenic 
artery and left gastric artery arose from the celiac 
artery.  Thromboembolic occlusion of the SMA,  celiac 
artery,  and splenic artery was revealed on the CT 
(Fig.  1A,  B).  The thrombus of the SMA was located 
on the proximal side of the common hepatic artery 
origin.  A large ﬂoating thrombus was also observed in 
the abdominal aorta that was contiguous with the 
thrombus in the celiac artery and SMA (Fig.  1A).  
The blood ﬂow in the distal portion of the SMA and 
the common hepatic artery was barely maintained by 
collateral ﬂow from the inferior mesenteric artery 
(IMA),  and the hepatic arteries appeared narrow.  The 
portal vein (PV) appeared signiﬁcantly small,  probably 
because of the reduction in mesenteric and splenic 
venous return (Fig.  1B).  In addition,  CT showed 
partial infarctions of the liver,  spleen,  and both kid-
neys (Fig.  1B).  Bowel-wall enhancement was normal 
throughout,  except that it was slightly reduced in a 
portion of the small intestine.
　 Because the patient had a history of atrial ﬁ brilla-
tion,  the presence of multiple cardiogenic emboli in the 
visceral arteries was suspected.  Although immediate 
endovascular treatment was considered an option,  we 
were concerned that catheter intervention might cause 
migration of the thrombi leading to peripheral embo-
lization.  Therefore,  systemic anticoagulant and 
thrombolytic therapy by transvenous administration of 
heparin and urokinase (UK) was selected as the initial 
treatment.  Continuous infusion of 600IU per hour of 
heparin and 20,000IU per hour of UK was initiated,  
followed by blood examination approximately 6h after 
admission.  The examination revealed markedly ele-
vated hepatic enzyme levels: AST,  ALT,  and LDH 
were 3,919IU/L,  3,789IU/L,  and 6,929IU/L,  
respectively.  However,  CK remained within the nor-
mal range,  and no other signs of bowel necrosis were 
observed.  We suspected that severe ischemic liver 
injury would be fatal if conservative therapy was 
continued; therefore,  we elected to perform emergent 
endovascular treatment.
　 We inserted a 6-French (Fr) sheath from the right 
femoral artery.  IMA angiography using a 4-Fr shep-
herd hook catheter showed collateral blood ﬂow from 
the IMA to the SMA,  a common hepatic artery arising 
from the SMA,  and scarcely delineated peripheral 
branches of the hepatic artery (Fig.  2A).  Total 
obstruction of the proximal SMA was observed on 
SMA angiography using a 6-Fr cobra-shaped guiding 
catheter (Brite Tip,  Cordis,  Miami Lakes,  FL,  
USA) (Fig.  2B).  A 0.035-inch guide wire was 
advanced past the embolus deep into the SMA,  and 
then a 4-Fr cobra-shaped catheter was inserted 
through the 6-Fr guiding catheter.  These catheters 
were advanced over the wire into the embolus.  
Embolus aspiration was performed using the 6-Fr and 
4-Fr catheters.  These catheters were extracted dur-
ing aspiration and re-introduced for further aspiration; 
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Fig. 1　 Dynamic computed tomography images on admission.  A,  An axial early-phase image of a slice at the level of the origin of the 
celiac artery.  The white arrow and arrowhead indicate thromboembolic occlusion of the celiac and splenic arteries,  respectively.  The 
black arrow indicates the ﬂoating thrombus in the abdominal aorta; B,  An axial portal-phase image of a slice at the level of the origin of 
the superior mesenteric artery (SMA).  The large arrow indicates thromboembolic occlusion of the proximal SMA.  The portal vein appears 
small (small arrow).  The arrowhead indicates partial infarctions of the kidney.
this process was repeated several times.  SMA angiog-
raphy after aspiration showed recanalization of the 
proximal SMA,  but severe stenosis due to the resid-
ual thrombus persisted.  Next,  pharmacomechanical 
thrombolysis was performed using a 4-Fr pulse-spray 
catheter (Fountain Infusion System,  Merit Medical,  
South Jordan,  UT,  USA).  The thrombolytic solution 
was prepared by dissolving 120,000 IU of UK in 
20mL of saline.  Pulse injections were applied by 
manual injection of 0.5-mL aliquots approximately 
every 30sec.  After thrombolysis,  the patency of the 
stenotic portion of the proximal SMA had slightly 
improved,  but further intervention appeared neces-
sary.  Subsequently,  percutaneous transluminal 
angioplasty (PTA) was performed using a balloon 
catheter (4mm in diameter; Sterling,  Boston 
Scientiﬁc,  Natick,  MA,  USA).  Unfortunately,  no 
further improvement in stenosis was observed on SMA 
angiography after PTA.  We therefore decided to 
perform stent placement.  Two stents (18mm and 
15mm long,  both 5mm in diameter; PALMAZ 
Genesis,  Cordis,  Miami Lakes,  FL,  USA) were 
placed covering the entire length of the stenotic por-
tion of the proximal SMA (Fig.  2C).  Thereafter,  a 
5-Fr shepherd hook catheter was placed in the proxi-
mal SMA,  and continuous infusion of UK was initiated 
at a rate of 10,000 IU per hour.
　 Transarterial infusion of UK was continued for 3 
days with concurrent systemic anticoagulant therapy 
with heparin.  Follow-up angiography performed on the 
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Fig. 2　 A,  Pre-treatment inferior mesenteric artery (IMA) angiography.  The SMA,  IMA,  and common hepatic artery (CHA) are indicated 
in the ﬁgure.  The arrowhead indicates the collateral vessel from the IMA to the SMA; B,  Pre-treatment SMA angiography (lateral view).  
Total obstruction of the proximal SMA is delineated; C,  SMA angiography (lateral view) 1 day after stent placement.  The stents were 
placed in the proximal SMA,  covering the entire length of the stenotic portion (arrow).  Recanalization of the SMA was demonstrated; D,  
SMA angiography performed on the 3rd hospital day.  Blood ﬂow of the SMA and the common hepatic artery is markedly improved,  and 
peripheral branches of the hepatic artery are articulately delineated.
third hospital day showed marked improvement in 
SMA and hepatic arterial blood ﬂow (Fig.  2D).  CT 
on the same day revealed a small amount of residual 
thrombus at the origin of the SMA.  The CT also 
revealed disappearance of the ﬂoating thrombus in the 
abdominal aorta and reduction of thrombus volume in 
the celiac and splenic arteries.  For prevention of stent 
thrombosis,  aspirin (100mg/d) therapy was started 
the day after continuous UK infusion was completed.  
Transvenous anticoagulant therapy was continued for 
10 days and was then switched to oral warfarin antico-
agulant therapy.  Hepatic enzyme levels steadily 
declined and had normalized by 2 weeks after admis-
sion (Fig.  3).  CT performed on the 18th hospital day 
showed disappearance of the residual thrombus in the 
SMA,  celiac artery,  and splenic artery.  The patient 
fully recovered and was discharged,  remaining asymp-
tomatic at the most recent visit,  approximately 1 year 
from the onset.
Discussion
　 Despite progress in diagnostic and treatment 
modalities,  a recent study showed that the mortality 
rate of acute SMA occlusion remains high,  at 
approximately 60ｵ [6].  Because bowel ischemia is 
generally the most critical complication,  rapid revas-
cularization is needed before bowel ischemia pro-
gresses to irreversible bowel necrosis.  The clinical 
course of the present case is interesting in the sense 
that ischemic liver injury,  rather than bowel ischemia,  
was the most critical problem that dictated the course 
of treatment.  To the best of our knowledge,  there are 
only 5 published case reports in English literature 
that describe acute SMA occlusion with ischemic liver 
injury (Table 1).  All previously reported cases pre-
sented with synchronous occlusion of the SMA and 
celiac artery.  Among them,  only 1 case underwent 
endovascular treatment.  Therefore,  the present case 
represents the second reported case describing endo-
vascular treatment for ischemic liver injury in asso-
ciation with acute SMA occlusion.  Furthermore,  
there have been no case reports of acute SMA occlu-
sion in a patient with anatomical variation of the 
hepatic artery,  as was the case in our patient.  
Because of this anatomical variation of the hepatic 
artery,  i.e., a common hepatic artery arising from the 
SMA,  the SMA embolism induced hepatic arterial 
hypoperfusion as well as mesenteric blood ﬂow reduc-
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Fig. 3　 Fluctuation of hepatic enzyme levels.  The levels of 
aspartate aminotransaminase (AST),  alanine aminotransaminase 
(ALT),  and lactate dehydrogenase (LDH) were elevated exponen-
tially on the day of admission; they declined steadily after catheter 
intervention,  and normalized by 2 weeks after admission.
Table 1　 Reported cases of acute SMA occlusion with ischemic liver injury
Author Age/Sex Etiology Occluded Artery Treatment Outcome
Semb et al. [1] 61/M Thrombus SMA and Celiac artery Surgical thrombectomy and necrotic 
bowel resection
Died
Gillet et al. [2] 55/F Not described SMA and Celiac artery Surgical thrombectomy and necrotic 
bowel resection
Recovered
Young et al. [3] 62/F Not described SMA, IMA, and Celiac artery Aortomesenteric bypass and necrotic 
bowel resection
Recovered
Rajkovic et al. [4] 70/F Embolus SMA and Celiac artery Only exploratory laparotomy Died
San Norberto et al. [5] 67/F Embolus SMA and Celiac artery Endovascular recanalization of SMA and 
celiac artery
Recovered
SMA,  superior mesenteric artery; IMA,  inferior mesenteric artery.
tion and subsequent portal hypoperfusion.  We assume 
that concurrent celiac and splenic artery embolism was 
also responsible for the development of severe liver 
ischemia because of the reduction in splenic venous 
ﬂow that resulted in portal hypoperfusion.
　 Because the common hepatic artery arose from the 
SMA in the present case,  we were able to success-
fully restore mesenteric and hepatic arterial ﬂow 
concurrently via SMA recanalization without catheter 
intervention for the celiac and splenic artery emboli.  
In the case of synchronous thromboembolism to the 
SMA and celiac artery in a patient with a normal 
hepatic artery arising from the celiac trunk,  interven-
tion for both the SMA and the celiac artery occlusion 
may be desirable,  as in the above-mentioned case 
report [5].  However,  the SMA should perhaps be 
given priority for recanalization,  given that SMA 
recanalization may contribute to restoration of both 
mesenteric and hepatic blood ﬂow due to collateral 
circulation via the pancreatic arcade.
　 Although laparotomy and surgical embolectomy are 
still major treatment procedures for acute SMA 
embolism,  endovascular recanalization of the SMA can 
be an alternative option in patients with no signs of 
bowel necrosis at the time of diagnosis.  Several stud-
ies have shown that endovascular treatment has been 
used with increased frequency for acute mesenteric 
ischemia in the last decade [7,  8].  The proportion of 
patients who undergo endovascular procedures for the 
treatment of acute mesenteric ischemia has been 
reported as 12-36ｵ,  varying by institution [6-8].  In 
the present case,  we performed a combination of 
trans-catheter embolus aspiration,  thrombolysis,  bal-
loon angioplasty,  and stent placement.  Recent studies 
have shown favorable outcomes following trans-cathe-
ter embolus aspiration and thrombolysis [9,  10].  
Although PTA has been described as a useful method 
to treat acute embolic SMA occlusion,  it is also asso-
ciated with a risk of peripheral embolization and 
potential further worsening of bowel ischemia [11].  
The eﬃcacy of the stent for acute SMA occlusion is 
indicated by several studies,  but the causes of occlu-
sion in the majority of reported cases were arterio-
sclerotic thrombosis or dissection of the SMA,  rather 
than cardiogenic embolism [10,  12].  There are only 
a few reported cases of stent placement for cardio-
genic SMA embolism [5,  12,  13].  Thus,  the indica-
tion for stent placement in such cases remains contro-
versial.  We ﬁrst attempted to revascularize the SMA 
by embolus aspiration and thrombolysis,  but the SMA 
and common hepatic artery ﬂow remained insuﬃcient 
after completion of these strategies.  Therefore,  we 
performed PTA and stent placement to secure hepatic 
inﬂow and avoid irreversible liver failure.  However,  
uncertainty regarding the long-term outcomes follow-
ing stent placement for acute SMA occlusion remains 
problematic.  Regarding chronic mesenteric ischemia,  
a recent study showed that the primary 1- and 2-year 
patency rates of stents placed in mesenteric arteries 
were 86ｵ and 60ｵ,  respectively; the primary-
assisted patency rates were 88ｵ and 79ｵ,  respec-
tively [14].  The long-time patency of SMA stents in 
acute settings remains unknown because of the lack of 
data.  Therefore,  careful follow-up to check for in-
stent stenosis is necessary,  and more cases are 
required before deﬁnitive determination of the long-
term utility of this technique can be completed.
　 In conclusion,  acute embolism of multiple visceral 
arteries is a rare but critical condition.  Severe isch-
emic liver injury may occur in the setting of synchro-
nous embolism of the SMA and celiac artery,  and 
these phenomena may have a critical impact on the 
choice of treatment strategies and prognosis.  
Endovascular treatment appears to have been an eﬀec-
tive treatment option in this rare clinical scenario.
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